Following the recommendation of the World Health Organization, flu vaccines undergo a change in strain composition annually to ensure maximum protection against viruses expected in that particular season. For the prevention of influenza in the 2017-2018 epidemic season in Ukraine, four vaccines with virus strains relevant for this season were re-registered. These vaccines, according to WHO recommendations, include the Michigan, Hong Kong, and Brisbane strains.
As reported by the Ministry of Health of Ukraine, the following vaccines have been re-registered: Influvac (manufacturer Abbott Biologicals B.V., Netherlands); Influenza vaccine (manufacturer Hualan Biological Bacterin Co., Ltd., China); GC FLU (manufacturer Green Cross Corporation, Korea); Vaxigrip (manufacturer Sanofi Pasteur, France).
Currently, these vaccines are undergoing expert evaluation by the State Expert Center of the Ministry of Health of Ukraine.
In accordance with national legislation, flu vaccinations are not included in the national vaccination calendar, therefore, flu vaccines are not purchased with state budget funds. They can be purchased using local budgets or other sources not prohibited by law.











